• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.

作者信息

Pallotto Carlo, Suardi Lorenzo Roberto, Esperti Sara, Tarquini Roberto, Grifoni Elisa, Meini Simone, Valoriani Alice, Di Martino Stefania, Cei Francesco, Sisti Eleonora, Piani Fiorella, Botta Annarita, Salomoni Elena, Baragli Filippo, Blanc Pierluigi

机构信息

Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, Bagno a Ripoli, Florence, Italy.

Section of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.

出版信息

Infect Dis (Lond). 2020 Sep;52(9):675-677. doi: 10.1080/23744235.2020.1778178. Epub 2020 Jun 16.

DOI:10.1080/23744235.2020.1778178
PMID:32543971
Abstract
摘要

相似文献

1
Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.2019冠状病毒病（COVID-19）中CD4/CD8比值升高作为危重症风险因素的回顾性多中心研究
Infect Dis (Lond). 2020 Sep;52(9):675-677. doi: 10.1080/23744235.2020.1778178. Epub 2020 Jun 16.
2
CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.CD4+T、CD8+T细胞计数与重症新型冠状病毒肺炎：一项荟萃分析。
J Infect. 2020 Sep;81(3):e82-e84. doi: 10.1016/j.jinf.2020.06.036. Epub 2020 Jun 20.
3
Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.2019年冠状病毒病（COVID-19）重症和危重症患者的临床病程：一项对比研究。
J Infect. 2020 Aug;81(2):e82-e84. doi: 10.1016/j.jinf.2020.05.021. Epub 2020 May 13.
4
Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors.使用经临床验证的蛋白酶抑制剂预防冠状病毒病的临床表现和疾病进展。
Crit Care. 2020 Aug 18;24(1):511. doi: 10.1186/s13054-020-03235-4.
5
Viral aetiology and clinical characteristics of acute respiratory tract infections in Shenzhen during epidemic of coronavirus disease 2019.2019年冠状病毒病流行期间深圳急性呼吸道感染的病毒病因及临床特征
Infect Dis (Lond). 2020 Aug;52(8):590-592. doi: 10.1080/23744235.2020.1769855. Epub 2020 May 26.
6
A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.2019 年冠状病毒病危重症婴儿病例，表现为持续减少的 T 淋巴细胞。
Pediatr Infect Dis J. 2020 Jul;39(7):e87-e90. doi: 10.1097/INF.0000000000002720.
7
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.2019冠状病毒病（COVID-19）感染的产科患者的症状与危重症
Obstet Gynecol. 2020 Sep;136(3):636-637. doi: 10.1097/AOG.0000000000004078.
8
A familial cluster of severe coronavirus disease 2019 that required intubation of all family members.一个严重的2019冠状病毒病家族聚集病例，该家族所有成员均需插管治疗。
Infect Dis (Lond). 2020 Oct;52(10):755-758. doi: 10.1080/23744235.2020.1784999. Epub 2020 Jul 2.
9
Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19.计算机断层扫描显示新冠病毒病危重症患者内脏脂肪增多。
Diabetes Care. 2020 Oct;43(10):e129-e130. doi: 10.2337/dc20-1333. Epub 2020 Aug 4.
10
Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: A multicenter retrospective cohort study.空腹血糖可预测COVID-19患者危重症的发生：一项多中心回顾性队列研究。
J Infect. 2020 Sep;81(3):e20-e23. doi: 10.1016/j.jinf.2020.07.006. Epub 2020 Jul 8.

引用本文的文献

1
Immune landscape in children with X-linked retinoschisis.患有X连锁视网膜劈裂症儿童的免疫图谱
BMC Immunol. 2025 Aug 8;26(1):59. doi: 10.1186/s12865-025-00741-4.
2
A Comprehensive Study of Cellular and Humoral Immunity in Dogs Naturally Exposed to SARS-CoV-2.对自然感染新冠病毒的犬类细胞免疫和体液免疫的综合研究。
Transbound Emerg Dis. 2024 Feb 21;2024:9970311. doi: 10.1155/2024/9970311. eCollection 2024.
3
Ad5-nCoV boosted vaccine and reinfection-induced memory T/B cell responses and humoral immunity to SARS-CoV-2: based on two prospective cohorts.
Ad5-nCoV 增强型疫苗和再感染诱导的记忆 T/B 细胞反应及体液免疫对 SARS-CoV-2 的作用：基于两项前瞻性队列研究。
Emerg Microbes Infect. 2024 Dec;13(1):2412619. doi: 10.1080/22221751.2024.2412619. Epub 2024 Oct 28.
4
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.在未接触过该病毒的 HIV 患者和 CD4/CD8 比值正常的人群中，预先存在对 SARS-CoV-2 具有细胞毒性作用的细胞群体。
Front Immunol. 2024 May 15;15:1362621. doi: 10.3389/fimmu.2024.1362621. eCollection 2024.
5
A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19.一项随机、安慰剂对照、双盲、平行组临床研究，旨在评估AEV01联合标准治疗方案对轻度COVID-19老年患者的疗效和安全性。
J Ayurveda Integr Med. 2024 Jan-Feb;15(1):100860. doi: 10.1016/j.jaim.2023.100860. Epub 2024 Feb 6.
6
The Impact of Past COVID-19 Infection on Selected Lymphocyte Subsets in Pediatric Patients.既往新冠病毒感染对儿科患者特定淋巴细胞亚群的影响
Vaccines (Basel). 2023 Mar 15;11(3):659. doi: 10.3390/vaccines11030659.
7
Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection.预测新型冠状病毒肺炎（SARS-CoV-2）感染患者对甲泼尼龙冲击治疗的反应。
Med Clin (Engl Ed). 2022 Dec 23;159(12):557-562. doi: 10.1016/j.medcle.2022.02.028. Epub 2022 Dec 15.
8
Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.比较 K18-hACE2 小鼠和叙利亚金黄地鼠 SARS-CoV-2 感染模型的发病机制。
Dis Model Mech. 2022 Nov 1;15(11). doi: 10.1242/dmm.049632. Epub 2022 Nov 11.
9
Transcriptomic clustering of critically ill COVID-19 patients.危重症 COVID-19 患者的转录组聚类。
Eur Respir J. 2023 Jan 27;61(1). doi: 10.1183/13993003.00592-2022. Print 2023 Jan.
10
Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.新型冠状病毒肺炎中的外周血T细胞淋巴细胞减少：潜在机制及影响
Immunother Adv. 2021 Jul 2;1(1):ltab015. doi: 10.1093/immadv/ltab015. eCollection 2021 Jan.